New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
12:22 EDTWLP, VOD, HUM, CSC, AAPL, MRVLGreen Light's Einhorn positive on Marvell, CSC, Vodafone
In its quarterly letter to investors, dated Jan. 22, David Einhorn's Greenlight Capital said it added to long positions in Marvell Technology (MRVL), Computer Sciences Corp. (CSC) and Vodafone (VOD). In reference to Marvell, Greenlight said it continued to buy Marvell shares after its sharp drop on its patent case loss. Greenlight said there are "many reasons" to expect the damages award to Carnegie Mellon to be substantially reduced or eliminated and that Marvell is making a product transition that is underappreciated by The Street. Greenlight said Computer Sciences has earnings power in excess of $4.00 and significant opportunities for margin improvement. Einhorn's fund said the market is undervaluing what Vodafone's share of the Verizon Wireless JV is worth to the company. Greenlight also noted that during the quarter it closed out long positions in Humana (HUM) and Wellpoint (WLP).
News For MRVL;CSC;VOD;AAPL;HUM;WLP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 >>
September 23, 2015
17:41 EDTCSCAT&T, CSC announce hybrid cloud management platform
Subscribe for More Information
16:00 EDTAAPLOptions Update; September 23, 2015
iPath S&P 500 VIX Short-Term Futures down 53c to 23.81 Option volume leaders: AAPL NFLX BAC FB BABA DOW RIG MU FCX PBR XOM JPM
15:27 EDTAAPLAlibaba unveils low-priced, payments-focused smartwatch, VentureBeat reports
Alibaba (BABA) has unveiled Pay Watch, a smartwatch to be priced at $160 and lower that supports mobile payments through the company's Alipay platform, said VentureBeat, which notes that there is still no official English-language announcement on the device. Some health features are also being advertised and comparisons to Apple's (AAPL) Watch "seem inevitable," though "certainly not on price," the blog added. Reference Link
11:19 EDTAAPLApple security breach larger than first thought, Sky News says
Subscribe for More Information
09:33 EDTAAPLActive equity options trading on open: AAPL BBRY BIDU BIIB
Subscribe for More Information
09:24 EDTAAPLT-Mobile announces $5 per month offer on iPhone 6s
On the cusp of iPhone 6s and iPhone 6s Plus availability, T-Mobile unveiled a $5 a month for iPhone 6s 16GB and $9 a month for iPhone 6s Plus 16GB with JUMP! On Demand and trade-in of an iPhone 6 or iPhone 6 Plus. T-Mobile's new pricing builds on the Un-carrier's straightforward $20 a month for a new iPhone 6s 16GB with JUMP! On Demand without a trade-in.
09:18 EDTAAPLPaulson Institute and CCPIT to co-host U.S.-China Business Roundtable
The Paulson Institute and the China Council for the Promotion of International Trade (CCPIT) provide an opportunity for U.S. and Chinese business leaders to discuss issues facing the two countries in a roundtable being held in Seattle, Washington on September 23.
08:11 EDTHUMLeerink sees less political risk for Managed Care mergers after hearings
Subscribe for More Information
07:28 EDTAAPLApple installment plans may accentuate seasonality, says UBS
Subscribe for More Information
September 22, 2015
20:02 EDTHUMClinton vows $250 cap on monthly drug costs in blast against biotechs, insurers
Democratic presidential candidate Hillary Clinton railed against biotech companies as well as health insurers at a community health care forum in Iowa on Tuesday. Clinton began her speech by praising the Affordable Care Act, but quickly noted that she wants to strengthen it due to what she called the rising cost of prescription drugs. She explained, "Our pharmaceutical and biotechnology industries deserve credit... [But] too often, these drugs cost a fortune. Now, sometimes there is a good reason for that. Scientific breakthroughs are often the result of major investment... so it may makes sense, for a short period of time, to have to charge a lot of money for a drug. But when a drug has no competition, when there aren't any other treatments that can do what it does, pharmaceutical companies can charge astronomical fees far beyond anything that it would take to recoup their investment, and far beyond what they charge consumers anywhere else in the world outside of America." Referencing the recent criticism against Turing Pharmaceuticals, Clinton went on to say that "pharmaceutical companies that acquire an existing affordable drug that people rely on, and then turn around and charge a fortune for it, [are just betting] on the fact that desperate people will find some way to pay for it." Preemptively responding to questions of whether greater regulation will dampen investment, Clinton commented that "some people worry that my proposals will threaten innovation, but I have designed a plan that will do exactly the opposite... Under my plan, drug companies that want to keep getting federal support will have to redirect more of their profits into meaningful investments in research and development." Clinton also criticized incremental drug improvements, saying that "too often, so-called new drugs are really old drugs that have just been tweaked a little bit, but then they're marketed as breakthrough drugs and they're sold for high prices." The Democratic candidate went on to condemn advertising in the drug industry, remarking that "I also want to tackle direct to consumer advertising... Other countries ban these ads because they are so often misleading. But at the very least, we shouldn't be encouraging them with corporate write-offs... Under my plan, we will instead use that taxpayer money to fund innovation... I would also like to make sure any ads the drug industry does run are approved by the FDA." Moving more broadly onto Medicaid and health insurers, Clinton stated, "I believe Medicare should be able to negotiate for lower prices for its members... I will require drug companies to provide higher rebates for prescription drugs to low income Medicare patients, just like they have to do for Medicaid patients... I think the insurance companies need to be put on notice." Providing more concrete details of her plan, Clinton concluded, "I will cap out of pocket drug costs for working families. You won't have to pay more than $250 a month for covered medications... Particularly for people who have a chronic illness. Also under my plan, you will be able to import cheaper drugs from other countries legally. If the medicine you need costs less in Canada, you should be able to buy it from Canada or any other country that meets our safety standards... I will also make sure we have more generics on the market [by boosting funding for] the FDA's office of generic drugs."
16:15 EDTAAPLGoPro CEO says does not believe Apple developing rival camera, Fortune reports
Subscribe for More Information
16:00 EDTAAPLOptions Update; September 22, 2015
Subscribe for More Information
14:52 EDTHUMAetna plans to raise Humana wages after merger, Bloomberg says
Aetna (AET) CEO Mark Bertolini plans to raise wages to $16 per hour for about 10,000 low-wage Humana (HUM) employees if the prospective merger of the two companies goes through, reports Bloomberg, citing written testimony at a U.S. Senate subcommittee hearing. "Our hope is these initiatives will help reduce employee turnover," explained Bertolini. Reference Link
12:55 EDTAAPLGoPro CEO says 'lots of conversations' with Apple, none about takeover
Nick Goodman is speaking on CNBC.
09:33 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:37 EDTHUMAetna, Anthem CEOs set to testify to Senate committee, WSJ reports
Subscribe for More Information
07:46 EDTAAPLFormer GM exec: Apple will lose money in car business, CNBC says
Apple (AAPL) could lose big money if it enters the electric car business, CNBC reports, citing comments from former General Motors (GM) vice chairman Bob Lutz. "There is absolutely no reason to assume that Apple is going to be financially successful in the electric car business," Lutz told CNBC. Reference Link
07:40 EDTAAPLApple may be overextending brand with car project, says UBS
Subscribe for More Information
07:29 EDTAAPLApple coverage assumed with a Buy at Goldman
Subscribe for More Information
06:40 EDTMRVLChip sector deal size up substantially in 2015, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use